|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/40 |
| (11) | Number of the document | 3169709 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15739763.9 |
| Date of filing the European patent application | 2015-07-13 | |
| (97) | Date of publication of the European application | 2017-05-24 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-12 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/040211 |
| Date | 2015-07-13 |
| (87) | Number | WO 2016/010924 |
| Date | 2016-01-21 |
| (30) | Number | Date | Country code |
| 201462024399 P | 2014-07-14 | US |
| (72) |
TWINKLE, Christian R., US
CLOGSTON, Christi L., US
OSSLUND, Timothy David, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, California 91320-1799,
US
|
| (54) | CRYSTALLINE ANTIBODY FORMULATIONS |
| CRYSTALLINE ANTIBODY FORMULATIONS |